National News

National News

House Speaker Nancy Pelosi, D-Calif., and Senate Minority Leader Chuck Schumer, D-N.Y., speak Sunday following a press conference on Capitol Hill after Republicans and Democrats finally came to an agreement on the coronavirus relief bill. CREDIT: Tasos Katopodis/Getty Images

Here Is What’s In Congress’ COVID-19 Relief Package

Congress plans to pass on Monday a bipartisan $900 billion COVID-19 relief bill after intense negotiations over its final details. Leaders of both parties are lauding the agreement, claiming victory for provisions they were able to get in — and keep out. The measure includes up to a $600 relief check for many Americans as well as an assortment of aid for small businesses and money to purchase and distribute vaccines. Continue Reading Here Is What’s In Congress’ COVID-19 Relief Package

Read More »
Senate Majority Leader Mitch McConnell wearing a face mask - December 2020

Congressional Leaders Reach $900 Billion Deal On Coronavirus Aid, Includes $600 Stimulus Payments

After months of partisan squabbling, congressional leaders have reached agreement on a nearly $900 billion COVID-19 relief package. “At long last, we have the bipartisan breakthrough the country has needed,” Senate Majority Leader Mitch McConnell, R-Ky., said on the Senate floor Sunday evening. Continue Reading Congressional Leaders Reach $900 Billion Deal On Coronavirus Aid, Includes $600 Stimulus Payments

Read More »
An empty syringe on a table at Ronald Reagan UCLA Medical Center after a care worker received the COVID-19 vaccine on Dec. 16, 2020. CREDIT: Brian van der Brug/AP

‘This Is An Exciting Thing.’ For Frontline Workers, Vaccine Comes As A Massive Relief

Tens of thousands of health care workers in cities and states all over the country got their first doses of the new Pfizer coronavirus vaccine this past week — a monumental undertaking both scientifically and logistically — and more than seven million doses of the Pfizer and newly-authorized Moderna vaccine are being shipped out this coming week. Continue Reading ‘This Is An Exciting Thing.’ For Frontline Workers, Vaccine Comes As A Massive Relief

Read More »
The facade of Moderna, Inc. headquarters is seen, Tuesday, Dec. 15, 2020, in Cambridge, Mass. The Food and Drug Administration said that a second potential COVID-19 vaccine, developed by Moderna, appears safe and highly effective, bringing it to the cusp of U.S. authorization. A panel of outside experts is expected to vote to recommend the formula on Thursday, with the FDA's green light coming soon thereafter. (AP Photo/Elise Amendola)

Moderna’s COVID-19 Vaccine Becomes 2nd To Earn FDA Authorization

On Friday, just one week after Pfizer and BioNTech’s COVID-19 vaccine received a federal green light, the Food and Drug Administration formally authorized a second vaccine for emergency use — this one developed by Moderna. The biotech upstart won authorization for use in adults following extensive federal analysis of the vaccine, which the FDA found to be 94% effective at preventing the disease. Continue Reading Moderna’s COVID-19 Vaccine Becomes 2nd To Earn FDA Authorization

Read More »
Deb Haaland poses for a picture with the Associated Press in New Mexico

In Historic Move, Rep. Deb Haaland Will Be Nominated As First Native American To Lead Interior

If confirmed by the Senate, Rep. Deb Haaland, a member of the Laguna Pueblo in New Mexico, would be the country’s first Native American Cabinet secretary. Fittingly, she’d do so as head of the agency responsible for not only managing the nation’s public lands but also honoring its treaties with the Indigenous people from whom those lands were taken. Continue Reading In Historic Move, Rep. Deb Haaland Will Be Nominated As First Native American To Lead Interior

Read More »